Cryo-Cell International, Inc. (CCEL)
CCEL Stock Price Chart
Explore Cryo-Cell International, Inc. interactive price chart. Choose custom timeframes to analyze CCEL price movements and trends.
CCEL Company Profile
Discover essential business fundamentals and corporate details for Cryo-Cell International, Inc. (CCEL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
4 Apr 1994
Employees
82.00
Website
https://www.cryo-cell.comCEO
David I. Portnoy
Description
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
CCEL Financial Timeline
Browse a chronological timeline of Cryo-Cell International, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Apr 2026
Upcoming earnings on 21 Oct 2025
Earnings released on 15 Jul 2025
EPS came in at $0.04 surpassing the estimated -$0.03 by +233.33%, while revenue for the quarter reached $7.93M , missing expectations by -0.65%.
Dividend declared on 8 May 2025
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 30 May 2025.
Earnings released on 28 Feb 2025
EPS came in at -$0.23 falling short of the estimated $0.01 by -2.40K%, while revenue for the quarter reached $7.97M , beating expectations by +1.09%.
Earnings released on 26 Feb 2025
EPS came in at $0.26 surpassing the estimated $0.01 by +2.50K%, while revenue for the quarter reached $8.02M , beating expectations by +0.45%.
Dividend declared on 29 Jan 2025
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 28 Feb 2025.
Earnings released on 15 Oct 2024
EPS came in at $0.13 surpassing the estimated $0.02 by +550.00%, while revenue for the quarter reached $8.07M , beating expectations by +0.99%.
Earnings released on 15 Jul 2024
EPS came in at $0.08 surpassing the estimated $0.04 by +100.00%, while revenue for the quarter reached $8.04M , beating expectations by +1.17%.
Earnings released on 15 Apr 2024
EPS came in at $0.07 surpassing the estimated -$0.00 by +1.82K%, while revenue for the quarter reached $7.85M , missing expectations by -0.98%.
Earnings released on 28 Feb 2024
EPS came in at $0.26 surpassing the estimated -$0.07 by +471.43%, while revenue for the quarter reached $7.88M , missing expectations by -0.42%.
Earnings released on 12 Oct 2023
EPS came in at $0.08 surpassing the estimated -$0.06 by +233.33%, while revenue for the quarter reached $7.87M , missing expectations by -0.51%.
Earnings released on 14 Jul 2023
EPS came in at $0.03 surpassing the estimated -$0.08 by +137.50%, while revenue for the quarter reached $7.77M , beating expectations by +0.03%.
Earnings released on 21 Apr 2023
EPS came in at $0.09 surpassing the estimated $0.02 by +324.93%, while revenue for the quarter reached $7.82M , beating expectations by +5.59%.
Earnings released on 28 Feb 2023
EPS came in at $0.10 surpassing the estimated $0.01 by +599.79%, while revenue for the quarter reached $7.76M .
Earnings released on 14 Oct 2022
EPS came in at $0.06 , while revenue for the quarter reached $7.68M .
Dividend declared on 22 Aug 2022
A dividend of $0.90 per share was announced, adjusted to $0.90. The dividend was paid on 9 Sept 2022.
Earnings released on 11 Jul 2022
EPS came in at $0.07 , while revenue for the quarter reached $7.63M .
Earnings released on 13 Apr 2022
EPS came in at $0.10 , while revenue for the quarter reached $7.26M .
Earnings released on 22 Feb 2022
EPS came in at -$0.08 , while revenue for the quarter reached $7.32M .
Earnings released on 15 Oct 2021
EPS came in at $0.10 , while revenue for the quarter reached $7.50M .
Earnings released on 15 Jul 2021
EPS came in at $0.14 , while revenue for the quarter reached $7.21M .
Earnings released on 14 Apr 2021
EPS came in at $0.08 , while revenue for the quarter reached $6.86M .
Earnings released on 24 Feb 2021
EPS came in at $0.15 , while revenue for the quarter reached $7.54M .
Earnings released on 15 Oct 2020
EPS came in at $0.10 , while revenue for the quarter reached $8.11M .
CCEL Stock Performance
Access detailed CCEL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.